Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

Active, not recruitingOBSERVATIONAL
Enrollment

8,670

Participants

Timeline

Start Date

March 30, 2009

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Anal CarcinomaCervical CarcinomaHuman Papillomavirus InfectionHuman Papillomavirus-Related Cervical CarcinomaOral Cavity Carcinoma
Interventions
OTHER

Cytology Specimen Collection Procedure

Correlative studies

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Long-term Follow-up

Undergo extended follow-up

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

50101

Agencia Costarricense de Investigaciones Biomédicas (ACIB), Liberia

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00867464 - Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls | Biotech Hunter | Biotech Hunter